Filing Flows

Filing Flows › Milestone Pharmaceuticals (MIST) › Next earnings date

Milestone Pharmaceuticals (MIST) earnings on Nov 13, 2026: what to expect

Milestone Pharmaceuticals (MIST) is expected to report earnings on Nov 13, 2026, in 5 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.21 (−$0.23 to −$0.20, 5 estimates) on revenue of $1.0M, against −$0.12 a year ago. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 64% chance of beating next time.

Report dateNov 13, 2026
Days to go5
EPS estimate−$0.21
Revenue estimate$1.0M
Beat rate50%

The last report

Milestone Pharmaceuticals reported revenue of $559K for the second quarter 2026, net loss $28.6M. How it makes money → · Every quarter →

Milestone Pharmaceuticals: EPS against the estimate, last 4 reportsMilestone Pharmaceuticals: EPS against the estimate, last 4 reportsEstimateReported−$0.17−$0.12Nov 25−$0.18−$0.15Mar 26$0.19−$0.20May 26−$0.19−$0.21Aug 26
Latest (Aug 26): Estimate −$0.19, Reported −$0.21.

Milestone Pharmaceuticals' latest quarter

Milestone Pharmaceuticals, Q2 2026: revenue $559K, net loss $28.6M, operating cash flow −$22.7M. The chart follows the revenue to costs, profit and cash.

Questions

When does MIST report earnings?

Milestone Pharmaceuticals is expected to report on Nov 13, 2026.

What are analysts expecting from Milestone Pharmaceuticals?

EPS of −$0.21 and revenue of $1.0M for the quarter.

Does Milestone Pharmaceuticals usually beat earnings?

It beat the consensus EPS estimate in 50% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.